Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations , 2018 for the quarter ended December 31, 2025, issued to Novartis India Limited ("The Company") ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has submitted to BSE a compliance certificate from its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited (formerly Link Intime), for the quarter ended December 31, 2025. The certificate confirms that all dematerialisation requests received from depository participants during the quarter were duly processed (accepted or rejected) and that the corresponding securities are listed on the stock exchanges. It also confirms that physical share certificates received for dematerialisation were cancelled after verification and the depositories' names were updated in the register of members within the timelines prescribed by SEBI. No requests for rematerialisation were received during the quarter.
This is a routine quarterly regulatory compliance filing with no material impact on the company's financials, operations, or shareholder value. Investors should not expect any stock price movement from this disclosure.